Enzymes involved in drug metabolism

Slides:



Advertisements
Similar presentations
CZ5225 Methods in Computational Biology Lecture 9: Pharmacogenetics and individual variation of drug response CZ5225 Methods in Computational Biology.
Advertisements

FDA Pharmacogenetic Labels A Clinical Perspective David A Flockhart MD, PhD Indiana University School of Medicine Clinical Pharmacology Subcommittee of.
Pharmacogenetics and the Management of Breast Cancer: Optimization of Tamoxifen Therapy Mark E. Sobel, M.D., Ph.D. Executive Officer American Society for.
Presentation Title February 23, 2011 Establishing Clinical-grade Assays for Support of Drug Trials May 3, 2012 Patrick Hurban Expression Analysis.
1 Pharmacogenetics: Improvement of Existing Drug Treatments Zhou Yan-Qiong.
Clinical implications of pharmacogenetic research S:t Petersburg April 4, 2008 Professor Leif Bertilsson Dept. of Clinical Pharmacology Karolinska University.
Genomics, Bioinformatics & Medicine
Dosing Regimen Individualization Pharmacogenomics: Use of genetic information to guide DR.
 Lotricia Guerrier, ARNP/CNS, CCNS, FNP-BC, CCRN.
RExPrimer Pongsakorn Wangkumhang, M.Sc. Biostatistics and Informatics Laboratory, Genome Institute, National Center for Genetic Engineering and Biotechnology.
Drug metabolism Prof. M. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague Cycle II, Subject: General pharmacology.
PHAR 751 Pharmacogenomics Sarah Brown, Pharm.D. Pharmacy Practice Resident Asante Health System
Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug metabolite ratios in blood Levo et al. Forensic Science International.
Kristen K. Reynolds, PhD Associate Medical Director, VP Laboratory Operations Copyright 2010 PGXL Laboratories LLC, Louisville KY All materials herein.
Copyright PGXL Laboratories, Louisville KY All materials herein are the exclusive property of PGXL Laboratories PGX Applications in Pain Management.
20 Beginning of the chapter
IF:Pain © PGXL Laboratories. Pain Management - Opioids Problem and Implications 2% to 40% of adults suffer from chronic pain 1 90% of patients.
Pharmacogenomics Eric Jorgenson.
IF:Cardiovascular © PGXL Laboratories.
By: Jessica Jeffries.  Isolated from Opium (agonist)  Metabolized to morphine (elicit analgesia)  Used to replace morphine (not thought to be addictive)
Pharmacogenetics and Pharmacogenomics Eric Jorgenson 2/24/9.
PHARMACOGENETICS, POPULATION STRUCTURE AND ADMIXTURE Guilherme Suarez-Kurtz Rio de Janeiro - Brazil Guilherme Suarez-Kurtz Rio de Janeiro - Brazil RS-ICSU-IAP.
PharmacogeneticsPharmacogenetics Dr, P Derakhshandeh, PhD Dr, P Derakhshandeh, PhD.
Conservation of genomic segments (haplotypes): The “HapMap” n In populations, it appears the the linear order of alleles (“haplotype”) is conserved in.
Pharmacogenetics & Pharmacogenomics Personalized Medicine.
Interactions Eric Jorgenson EPI 217 2/22/11. Outline Gene-Environment Interaction Gene-Gene Interaction Pharmacogenetics Pharmacogenomics.
Drug Metabolism and Pharmacogenetics Brendan Stamper University of Washington Dept. of Medicinal Chemistry.
PHAR 751 Pharmacogenomics
Dr. Muslim Suardi, MSi., Apt.
How Genetic Variants Impact the Safety and Effectiveness of Drugs Pharmacogenetics © PGXL Laboratories.
Introduction to Pharmacology Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology.
Pharmacogenomics: Improving the Dynamic of Care in Medication Management 1.
약물유전체학 Pharmacogenomics Kangwon National Univ School of Medicine Hee Jae Lee PhD.
Pharmacogenetics/Pharmacogenomics. Outline Introduction  Differential drug efficacy  People react differently to drugs Why does drug response vary?
Precision Healthcare: Pharmacogenomics & Pain Management
Pharmacogenetics of warfarin dosing
Pharmacogenomics: Genetic Factors Influencing Drug Response
Pharmacogenetics of warfarin dosing
Common variants vs Rare variants
Pharmacogenomics: towards personalized medicine
Molecular Biology of Opioid Analgesia
The Evaluation of CYP2D6, CYP2C9 and CYP2C19 Polymorphisms for Personalized Medicine in Psychiatry Patients Ebru DÜNDAR YENILMEZ1, Onur KARAYTUG2, Lut.
Endogenous and exogenous factors contribute to variability in drug effects physiological pathological genetic Goodman and Gilman, 2011.
TOWARDS ELECTRONIC PHARMACOGENOMIC ASSISTANCE AND TRANSLATION SERVICES
Introduction to Pharmacology
Pharmacogenomics Identification of genes variants that influence drug effects. Is it possible to predict the effect of a drug in a certain patient? Pharmacogenetics/genomics.
The Evaluation of CYP2D6, CYP2C9 and CYP2C19 Polymorphisms for Personalized Medicine in Physiciatry Patients Ebru DUNDAR YENILMEZ1, Onur KARAYTUG2, Lut.
Pharmacogenetic effects on pharmacokinetics and pharmacodynamics
Mahla sattarzadeh Kerman University of Medical Sciences
Genomic and therapy Anti-PCSK9 (evolocumab) for hypercolesteolemia
Beatriz Pérez González 2017/18 Genomics
Figure 2 Copy-number variations in multiple myeloma
BY : PHARMACOGENETICS V L Srividya, II Pharm.D(PB), N.E.T. PC,Raichur.
Conceptual Subdivisions of Pharmacology
PERSONALISING DRUG PRESCRIPTION BASED ON OUR GENETICS?
Conceptual Subdivisions of Pharmacology
Obstructive sleep apnoea in children: perioperative considerations
Introduction to Pharmacogenomics
Pharmacogenomics Genes and Drugs.
Safe and Appropriate Use of Opiates
Pharmacogenetics and Pharmacoepidemiology “PHCY 480”
Preemptive Pharmacogenomic Testing for Precision Medicine
Clinical Pharmacokinetics
Clinical Implications of Opioid Pharmacogenomics
Seyed Mostafa Mirakbari MD
Introduction to Pharmacogenetics
The principles of genetic association
Molecular Biology of Opioid Analgesia
The future TB clinic. The future TB clinic. Sputum, saliva, and fecal samples are collected from patients for genome sequencing, SNP typing, or metagenomic.
Pharmacogenomics Identification of genes variants that influence drug effects. Is it possible to predict the effect of a drug in a certain patient? Pharmacogenetics/genomics.
Presentation transcript:

Enzymes involved in drug metabolism Goodman and Gilman, 2011

Drug metabolism: phenytoin Goodman and Gilman, 2011

Intracellular localization of drug metabolizing enzymes Goodman and Gilman, 2011

Chemical formula of morphine

Chemical structures of opioids

Pharmacokinetics codeine and morphine Thorn et al., Pharmacogenetics & Genomics 2009

6-glucoronide metabolites of morphine is more active than morphine Dose from 5 to 37.5 mg morphine every 6 hours De Gregorti et al., Ther Drug Monit 2014

Tramadol Synthetic opioid of the family of derivatives of amminocycloesanol. Tramadol acts as an opioid agonist and also as an adreneric and serotoninergic agonist.

Tramadol biotransformation (+) - M1: has an activity increased 300-400 for the  opioid receptor

Other opioid agonists Fentanyl

Pharmacokinetics of codeine, morphine and their metabolites and activity of CYP2D6 EM = extensive metabolizer UM = ultra-rapid metabolizer PM = poor metabolizer Kirchheiner et al., Pharmacogenomics J 2007

Reduced efficacy of codeine in patients with reduced activity of CYP2D6

Frazione dei farmaci utilizzati in clinica metabolizzati dai piu’ importanti enzimi di fase 1 e fase 2 Goodman and Gilman, 2011

4-IDROSSIDEBRISOCHINA CYP2D6 DEBRISOCHINA 4-IDROSSIDEBRISOCHINA Immagine presa da Weinshilboum R. et al., NEJM 348(6), 2006 Weinshilboum R. et al., NEJM 2006

Genetic polymorphisms of CYP2D6 Gene located on chromosome 22 More than 100 variants for this gene have been characterized (www.cypalleles.ki.se/cyp2d6.htm). SNPs and insertions/deletions may reduce the activity of this enzyme (~10% of the population). Some subjects inherit multiple copies of the gene and display very high activity (2% or more of the population).

Molecular characteristic of CYP2D6 polymorphisms - SNP - deletions - base repetitions *4 *6 *3 Deletion of the gene Amplification of the gene

Frequency of CYP2D6 polymorphisms in the Italian population Scordo et al., Pharm Res 2004